Research

Energy balance

The tolerability and key adverse events associated with these AOMs appear to be acceptable in randomized controlled trials.

Clinicians can be reassured about the safety profile of newer AOMs based on trial data.

StrongSupportsmedium confidence
While the tolerability and key adverse events associated with these AOMs appear to be acceptable in randomized controlled trials.
Subir Ray et al. · Expert Review of Clinical Pharmacology · 2024

Why this rating

The claim is based on findings from randomized controlled trials.

Source

An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update

Subir Ray et al. · Expert Review of Clinical Pharmacology · 2024

DOI 10.1080/17512433.2024.2330468

otherCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →